Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pharmacyclics Inc (PCYC)    
$124.39 0.44 (0.35%) as of 4:30 Fri 8/29


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 73,583,000 as of 6/30
Market Cap: 9.15(B)
Last Volume: 423,018 Avg Vol: 842,502
52 Week Range: $85.85 - $151.61
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Pharmacyclics is a biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. Co. has three proprietary drug candidates under clinical development and several preclinical lead molecules: an inhibitor of Bruton's tyrosine kinase (BTK) ibrutinib in several Phase III studies in hematologic malignancies, a BTK inhibitor lead optimization program targeting anti-inflammatory and autoimmune indications, an inhibitor of Factor VIIa in a Phase II clinical trial in pancreatic cancer and a histone deacetylase inhibitor, abexinostat, in Phase I and II clinical trials in solid tumors and hematological malignancies.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 49,562 115,097 292,932 697,968
Total Sell Value $6,024,458 $15,121,805 $37,166,988 $64,623,106
Total People Sold 4 8 11 14
Total Sell Transactions 4 11 20 43
End Date 2014-06-01 2014-02-28 2013-08-30 2012-08-30

   
Records found: 354
  Page 1 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Love Richard B General Counsel   •       –      –    2014-08-27 4 S $124.00 $186,000 D/D (1,500) 204 -1%     
   Love Richard B General Counsel   •       –      –    2014-08-27 4 OE $32.38 $48,570 D/D 1,500 1,704     -
   Tan Heow Chief Quality&Tech Operations   •       –      –    2014-08-21 4 OE $27.05 $59,402 D/D 2,196 4,069     -
   Tomasello Shawn Chief Commercial OfficerOffice   •       –      –    2014-08-18 3 IO $0.00 $0 I/I 0 202 2%     
   Tomasello Shawn Chief Commercial Officer   •       –      –    2014-08-18 4 A $0.00 $0 D/D 62,500 62,500     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-08-13 4 S $121.01 $484,040 D/D (4,000) 3,192 -1%     
   Tan Heow Chief Quality&Tech Operations   •       –      –    2014-08-13 4 OE $27.05 $270,500 D/D 10,000 11,873     -
   Tan Heow Chief Quality&Tech Operations   •       –      –    2014-08-13 4 S $123.58 $1,235,808 D/D (10,000) 1,873 -1%     
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-08-13 4 OE $6.84 $27,360 D/D 4,000 7,192     -
   Mcgreivy Jesse Chief Medical Officer   •       –      –    2014-08-07 4 S $120.92 $4,118,610 D/D (34,062) 0 -3%     
   Mcgreivy Jesse Chief Medical Officer   •       –      –    2014-08-07 4 OE $25.33 $2,489,515 D/D 34,062 34,062     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-07-22 4 A $0.00 $0 D/D 6,000 38,610     -
   Sjovall Boultbee Paula S EVP, Sales and Marketing   •       –      –    2014-05-08 4 OE $25.94 $199,997 D/D 7,710 9,653     -
   Sjovall Boultbee Paula S EVP, Sales and Marketing   •       –      –    2014-04-30 4 A $80.39 $16,400 I/I 204 2,932     -
   Erdtmann Rainer M Sr. VP, IR and Admin   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 5,701     -
   Outten Matthew VP, Commercial Operations   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 10,758     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 32,610     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 210,311     -
   Sjovall Boultbee Paula S EVP, Sales and Marketing   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 1,943     -
   Love Richard B General Counsel   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 204     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 3,192     -
   Tan Heow Chief Quality&Tech Operations   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 1,873     -
   Sjovall Boultbee Paula S EVP, Sales and Marketing   •       –      –    2014-04-29 4 OE $57.16 $133,297 I/I 2,332 2,728     -
   Outten Matthew VP, Commercial OperationsOffic   •       –      –    2014-03-10 3 IO $0.00 $0 I/I 0 180 -8%     
   Outten Matthew VP, Commercial OperationsOffic   •       –      –    2014-03-10 3 IO $0.00 $0 D/D 0 10,554 -8%     

  354 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed